{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T05:30:00Z","timestamp":1771306200157,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Protein Expression and Purification"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.pep.2021.105833","type":"journal-article","created":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T08:56:01Z","timestamp":1611996961000},"page":"105833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["An improved production and purification protocol for recombinant soluble human fibroblast activation protein alpha"],"prefix":"10.1016","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3620-0771","authenticated-orcid":false,"given":"Cecy R.","family":"Xi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Di Fazio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveed Ahmed","family":"Nadvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8136-2772","authenticated-orcid":false,"given":"Michelle Sui Wen","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4699-4237","authenticated-orcid":false,"given":"Hui Emma","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrika","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi Sharifi","family":"Tabar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2098-8322","authenticated-orcid":false,"given":"Xin Maggie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles G.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey W.","family":"McCaughan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8033-5518","authenticated-orcid":false,"given":"W. Bret","family":"Church","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0528-2604","authenticated-orcid":false,"given":"Mark D.","family":"Gorrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.pep.2021.105833_bib1","doi-asserted-by":"crossref","first-page":"129636","DOI":"10.1016\/j.bbagen.2020.129636","article-title":"Human proline specific peptidases: a comprehensive analysis","volume":"1864","author":"Dunaevsky","year":"2020","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"4","key":"10.1016\/j.pep.2021.105833_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1042\/CS20040302","article-title":"Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders","volume":"108","author":"Gorrell","year":"2005","journal-title":"Clin. Sci."},{"issue":"14","key":"10.1016\/j.pep.2021.105833_bib3","first-page":"3327","article-title":"Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin","volume":"53","author":"Rettig","year":"1993","journal-title":"Canc. Res."},{"issue":"6","key":"10.1016\/j.pep.2021.105833_bib4","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/hep.510290631","article-title":"Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis","volume":"29","author":"Levy","year":"1999","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.pep.2021.105833_bib5","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/hep.20853","article-title":"Fibroblast activation protein increases apoptosis, cell adhesion and migration by the LX-2 human stellate cell line","volume":"42","author":"Wang","year":"2005","journal-title":"Hepatology"},{"issue":"7774","key":"10.1016\/j.pep.2021.105833_bib6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","article-title":"Targeting cardiac fibrosis with engineered T cells","volume":"573","author":"Aghajanian","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.pep.2021.105833_bib7","first-page":"244806","article-title":"The latest developments in imaging fibroblast activation protein (FAP)","volume":"120","author":"Altmann","year":"2020","journal-title":"J. Nucl. Med."},{"issue":"21","key":"10.1016\/j.pep.2021.105833_bib8","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/eurheartj\/ehq519","article-title":"Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata","volume":"32","author":"Brokopp","year":"2011","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.pep.2021.105833_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2741\/4706","article-title":"Fibroblast activation protein in liver fibrosis","volume":"24","author":"Lay","year":"2019","journal-title":"Frontiers in Bioscience, Landmark"},{"issue":"2","key":"10.1016\/j.pep.2021.105833_bib10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1034\/j.1600-0676.2002.01503.x","article-title":"Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection","volume":"22","author":"Levy","year":"2002","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.pep.2021.105833_bib11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00259-020-04882-z","article-title":"Fibroblast imaging of hepatic carcinoma with (68)Ga-FAPI-04 PET\/CT: a pilot study in patients with suspected hepatic nodules","volume":"48","author":"Shi","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.pep.2021.105833_bib12","article-title":"Deletion of fibroblast activation protein provides atheroprotection","author":"Stein","year":"2020","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.pep.2021.105833_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ijc.2910580314","article-title":"Fibroblast activation protein: purification, epitope mapping and induction by growth factors","volume":"58","author":"Rettig","year":"1994","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.pep.2021.105833_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.fob.2013.12.001","article-title":"Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs","volume":"4","author":"Keane","year":"2014","journal-title":"FEBS Open Bio"},{"issue":"1","key":"10.1016\/j.pep.2021.105833_bib15","doi-asserted-by":"crossref","first-page":"12524","DOI":"10.1038\/s41598-017-12900-8","article-title":"Selective homogeneous assay for circulating endopeptidase fibroblast activation protein (FAP)","volume":"7","author":"Bainbridge","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.pep.2021.105833_bib16","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1021\/acsmedchemlett.9b00191","article-title":"Novel small molecule-derived, highly selective substrates for fibroblast activation protein (FAP)","volume":"10","author":"De Decker","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.pep.2021.105833_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.abb.2006.11.006","article-title":"Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV","volume":"457","author":"Christiansen","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"issue":"11","key":"10.1016\/j.pep.2021.105833_bib18","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1074\/jbc.M115.710582","article-title":"Fibroblast activation protein cleaves and inactivates fibroblast growth factor 21","volume":"291","author":"Dunshee","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.pep.2021.105833_bib19","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1182\/blood-2005-08-3452","article-title":"Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein","volume":"107","author":"Lee","year":"2006","journal-title":"Blood"},{"issue":"51","key":"10.1016\/j.pep.2021.105833_bib20","doi-asserted-by":"crossref","first-page":"36505","DOI":"10.1074\/jbc.274.51.36505","article-title":"Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts","volume":"274","author":"Park","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pep.2021.105833_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.peptides.2015.11.004","article-title":"Neuropeptide Y is a physiological substrate of fibroblast activation protein: enzyme kinetics in blood plasma and expression of Y2R and Y5R in human liver cirrhosis and hepatocellular carcinoma","volume":"75","author":"Wong","year":"2016","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.pep.2021.105833_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1074\/mcp.RA118.001046","article-title":"Identification of novel natural substrates of fibroblast activation protein - alpha by differential degradomics and proteomics","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol. Cell. Proteomics"},{"issue":"5","key":"10.1016\/j.pep.2021.105833_bib23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1042\/BJ20151085","article-title":"Circulating FGF21 proteolytic processing mediated by fibroblast activation protein","volume":"473","author":"Zhen","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.pep.2021.105833_bib24","article-title":"Overcoming stromal barriers to immuno-oncological responses via fibroblast activation protein-targeted therapy","author":"Brennen","year":"2020","journal-title":"Immunotherapy"},{"issue":"8","key":"10.1016\/j.pep.2021.105833_bib25","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1742-4658.2011.08051.x","article-title":"Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-\u03b1","volume":"278","author":"Keane","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.pep.2021.105833_bib26","doi-asserted-by":"crossref","first-page":"19441","DOI":"10.1074\/jbc.C500092200","article-title":"Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha","volume":"280","author":"Aertgeerts","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.pep.2021.105833_bib27","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1021\/bi701921b","article-title":"Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites","volume":"47","author":"Aggarwal","year":"2008","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.pep.2021.105833_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s41181-020-00102-z","article-title":"Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA(5m) chelators","volume":"5","author":"Moon","year":"2020","journal-title":"EJNMMI Radiopharmacy and Chemistry"},{"key":"10.1016\/j.pep.2021.105833_bib29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/1874940200801010052","article-title":"Reversible inactivation of human dipeptidyl peptidases 8 and 9 by oxidation","volume":"1","author":"Park","year":"2008","journal-title":"Open Enzym. Inhib. J."},{"issue":"7","key":"10.1016\/j.pep.2021.105833_bib30","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.bbapap.2014.03.015","article-title":"A rare variant in human fibroblast activation protein associated with ER stress, loss of enzymatic function and loss of cell surface localisation","volume":"1844","author":"Osborne","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.pep.2021.105833_bib31","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1006\/prep.2001.1572","article-title":"Expression, purification, and kinetic characterization of full-length human fibroblast activation protein","volume":"24","author":"Sun","year":"2002","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.pep.2021.105833_bib32","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.3390\/molecules25225392","article-title":"A novel purification procedure for active recombinant human DPP4 and demonstrating an inability of DPP4 to bind SARS_CoV_2 spike protein","volume":"25","author":"Xi","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.pep.2021.105833_bib33","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.2741\/2918","article-title":"Fibroblast activation protein and chronic liver disease","volume":"13","author":"Wang","year":"2008","journal-title":"Front. Biosci."},{"issue":"5","key":"10.1016\/j.pep.2021.105833_bib34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nmeth.1318","article-title":"Enzymatic assembly of DNA molecules up to several hundred kilobases","volume":"6","author":"Gibson","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1016\/j.pep.2021.105833_bib35","volume":"MAN0000414","author":"Gibco","year":"2018"},{"key":"10.1016\/j.pep.2021.105833_bib36","series-title":"A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures. Texas Agriculture Experiment Station Bulletin","first-page":"1555","author":"Summers","year":"1987"},{"issue":"20","key":"10.1016\/j.pep.2021.105833_bib37","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1046\/j.1432-1327.2000.01617.x","article-title":"Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8","volume":"267","author":"Abbott","year":"2000","journal-title":"Eur. J. Biochem."},{"issue":"7","key":"10.1016\/j.pep.2021.105833_bib38","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1158\/1541-7786.MCR-10-0272","article-title":"A novel role of dipeptidyl peptidase 9 in epidermal growth factor signaling","volume":"9","author":"Yao","year":"2011","journal-title":"Mol. Canc. Res."},{"issue":"9","key":"10.1016\/j.pep.2021.105833_bib39","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1021\/jm400351a","article-title":"Identification of selective and potent inhibitors of fibroblast activation protein and prolyl oligopeptidase","volume":"56","author":"Poplawski","year":"2013","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.pep.2021.105833_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184366","article-title":"Large scale expression and purification of secreted mouse hephaestin","volume":"12","author":"Deshpande","year":"2017","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.pep.2021.105833_bib41","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12038-013-9333-8","article-title":"Effect of zinc and calcium ions on the rat kidney membrane-bound form of dipeptidyl peptidase IV","volume":"38","author":"Gomez","year":"2013","journal-title":"J. Biosci."},{"issue":"5","key":"10.1016\/j.pep.2021.105833_bib42","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1006\/prep.1993.1046","article-title":"Enhanced expression, secretion, and large-scale purification of recombinant HIV-1 gp120 in insect cell using the baculovirus egt and p67 signal peptides","volume":"4","author":"Murphy","year":"1993","journal-title":"Protein Exprression and Purification"},{"issue":"10","key":"10.1016\/j.pep.2021.105833_bib43","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","article-title":"Fusion protein linkers: property, design and functionality","volume":"65","author":"Chen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.pep.2021.105833_bib44","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1110\/ps.03460604","article-title":"Crystal structure of human Dipeptidyl Peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation","volume":"13","author":"Aertgeerts","year":"2004","journal-title":"Protein Sci."},{"issue":"6","key":"10.1016\/j.pep.2021.105833_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178987","article-title":"Circulating fibroblast activation protein activity and antigen levels correlate strongly when measured in liver disease and coronary heart disease","volume":"12","author":"Uitte de Willige","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.pep.2021.105833_bib46","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1074\/mcp.M114.038836","article-title":"Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer","volume":"13","author":"Nazarian","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"issue":"2","key":"10.1016\/j.pep.2021.105833_bib47","doi-asserted-by":"crossref","first-page":"108252","DOI":"10.1016\/j.celrep.2020.108252","article-title":"Identification of fibroblast activation protein as an osteogenic suppressor and anti-osteoporosis drug target","volume":"33","author":"Wei","year":"2020","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.pep.2021.105833_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240195","article-title":"Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease","volume":"15","author":"Kim","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.pep.2021.105833_bib49","article-title":"State-of-the-Art: FAPI PET\/CT-Will it end the hegemony of FDG in oncology?","author":"Hicks","year":"2020","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.pep.2021.105833_bib50","doi-asserted-by":"crossref","first-page":"21280","DOI":"10.1038\/s41598-020-77978-z","article-title":"Discovery of a novel fibroblast activation protein (FAP) inhibitor, BR103354, with anti-diabetic and anti-steatotic effects","volume":"10","author":"Cho","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Protein Expression and Purification"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592821000164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592821000164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:54:49Z","timestamp":1760925289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046592821000164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":50,"alternative-id":["S1046592821000164"],"URL":"https:\/\/doi.org\/10.1016\/j.pep.2021.105833","relation":{},"ISSN":["1046-5928"],"issn-type":[{"value":"1046-5928","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An improved production and purification protocol for recombinant soluble human fibroblast activation protein alpha","name":"articletitle","label":"Article Title"},{"value":"Protein Expression and Purification","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pep.2021.105833","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105833"}}